TG Therapeutics (TGTX) secures a new $750M Blue Owl credit facility, netting $500M non-dilutive capital and boosting buybacks to $300M—read the update.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results